No FDA approved drug and closest drug being developed is Aptoll which has a 40 percent infarct protection compared to 86 percent with NYR as shown below. A 4 billion dollar market they will dominate and own now just first human dosing 1 month away
Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.020(5.71%) |
Mkt cap ! $66.43M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 31.0¢ | $119.0K | 367.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6400 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 59677 | 4 |
View Market Depth
| Last trade - 14.00pm 22/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |